Serotonin Receptor Agonists: all 773 studies that test it
Page 8 of 8. Open to participants first (148), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess an Auto-injector Being Used to Treat a Migraine AttackCompletedNCT00510419Phase 3
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male SubjectsCompletedNCT00505973Phase 1
- Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic ConstipationTerminatedNCT00501241Phase 2
- A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of PrucaloprideCompletedNCT00488215Phase 1
- Efficacy and Safety Study of Prucalopride to Treat Chronic ConstipationCompletedNCT00488137Phase 3
- Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic ConstipationCompletedNCT00487422Phase 3
- Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic ConstipationCompletedNCT00485940Phase 3
- Efficacy and Safety Study of Prucalopride for the Treatment of Chronic ConstipationCompletedNCT00483886Phase 3
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine HeadacheCompletedNCT00471952Phase 3
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female SubjectsCompletedNCT00458107Phase 1
- Safety, PK and PD Study in Healthy Male Japanese SubjectsCompletedNCT00447941Phase 1
- The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 MonthsCompletedNCT00442221Phase 3
- Detoxification and Treatment of Subjects With Medication Overuse HeadacheStatus unknownNCT00432549Phase 4
- Study Evaluating SCA-136 Tolerability With Dose Titration and FoodTerminatedNCT00420706Phase 1
- Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.TerminatedNCT00414024Phase 3
- Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and NicardipineStatus unknownNCT00409253Phase 3
- An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.CompletedNCT00407095Phase 3
- Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.TerminatedNCT00399659Phase 3
- Neuropeptides in the Humane Intra- og Extracerebral Circulation.CompletedNCT00399633Not applicable
- Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster HeadacheStatus unknownNCT00399243Phase 4
- Effect of Tegaserod on Gastric Emptying in Patients With Diabetic GastroparesisTerminatedNCT00390975Phase 4
- Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)CompletedNCT00367822Phase 3
- Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer PainTerminatedNCT00365820Phase 2/3
- A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana DependenceCompletedNCT00360191Phase 2
- Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation PatientsTerminatedNCT00348634Phase 4
- An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsCompletedNCT00335374Phase 3
- Dexmed/Buspirone Synergism on ShiveringCompletedNCT00334360Phase 4
- An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsCompletedNCT00332917Phase 3
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With DysmenorrheaCompletedNCT00329459Phase 3
- Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)CompletedNCT00329355Phase 3
- Effects of Buspirone in Opiate WithdrawalCompletedNCT00326235Phase 4
- Effects of Psilocybin in Advanced-Stage Cancer Patients With AnxietyCompletedNCT00302744Phase 1/2
- Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderCompletedNCT00290914Phase 2
- Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With ResponseCompletedNCT00285376Phase 3
- Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment OrderTerminatedNCT00282165Phase 4
- SLV308 for Treatment of Patients With Early Parkinson's DiseaseCompletedNCT00269516Phase 3
- Study Evaluating SCA-136 in Subjects With Acute Exacerbations of SchizophreniaCompletedNCT00265551Phase 2
- Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksCompletedNCT00240617Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232102Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232089Phase 3
- Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of DyspepsiaCompletedNCT00232037Phase 3
- Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With DyspepsiaCompletedNCT00232024Phase 3
- Effect of Oral 5-HTP Intake on Urinary 5-HIAA ExcretionTerminatedNCT00227136Phase 3
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-cCompletedNCT00215566Phase 2
- The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine PainCompletedNCT00212823Phase 4
- A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine HeadacheCompletedNCT00210509Phase 4
- Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCompletedNCT00210496Phase 4
- A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in AdolescentsCompletedNCT00210483Phase 3
- A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of MigraineCompletedNCT00174395Phase 4
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and BusparCompletedNCT00174226Phase 2
- Preference of Tegaserod vs. PEG 3350 in Patients With ConstipationCompletedNCT00171522Phase 4
- Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171483Phase 3
- The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.CompletedNCT00171470Phase 3
- The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNCT00171457Phase 3
- The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)TerminatedNCT00171431Phase 3
- Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171418Phase 3
- Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and EfficacyCompletedNCT00166621Phase 1/2
- Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic ConstipationCompletedNCT00149877Phase 4
- A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00149851Phase 2
- Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1CompletedNCT00149617Phase 2
- Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSCompletedNCT00142987Phase 4
- Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic GastropathyTerminatedNCT00142974Phase 2
- Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.CompletedNCT00141089Phase 3
- An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic ConstipationCompletedNCT00139568Phase 3
- Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's DiseaseCompletedNCT00134251Phase 3
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00116740Phase 2
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00104507Phase 2
- Repinotan in Patients With Acute Ischemic StrokeCompletedNCT00044915Phase 2
- Infusion Laboratory: Protocol 2 (Lisuride) - 3Status unknownNCT00000338Phase 1
- M-CPP and Fenfluramine in Cocaine Addicts - 3CompletedNCT00000314Phase 2
- Alterations in Serotonergic Functions in Cocaine Addicts - 1CompletedNCT00000312Phase 1
- Gepirone vs Placebo in Treatment of Cocaine Dependence - 3CompletedNCT00000189Phase 2